Kit for detecting active pulmonary tuberculosis
A tuberculosis and active technology, applied in the field of kits for detecting active tuberculosis, can solve the problems of unreliability, lack of tuberculosis-specific serum miRNAs composition research reports, and low specificity, achieving high accuracy and design Accurate, early warning and early diagnosis effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] A diagnostic kit for detecting active pulmonary tuberculosis, the kit has RNA extraction buffer, active pulmonary tuberculosis specific serum miRNA composition: hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 and internal reference reverse transcription primers and PCR primers, fluorescent quantitative RT-PCR reaction solution.
[0032] The reverse transcription primer sequence is:
[0033]hsa-miR-29c:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTAACCG-3';hsa-miR-22:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGTT-3';hsa-miR-320b:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCCGTT-3';hsa-miR-101:5' -GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTTCAGT-3';
[0034] Internal reference hsa-miR-16: 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCCAA-3'.
[0035] The PCR upstream primer sequence is:
[0036] hsa-miR-29c: 5'-GGCGGTAGCACCATTTGAA-3';
[0037] hsa-miR-22: 5'-CGGAAGCTGCCAGTTGAAGA-3';
[0038] hsa-miR-320b: 5'-AAAAGCTGGGTTGAGAGGGCA-3';
[0039...
Embodiment 2
[0047] Example 2 Kit application
[0048] Detect the expression levels of hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 in the serum of patients with active pulmonary tuberculosis, healthy controls, lung cancer patients, pneumonia patients and patients with chronic obstructive pulmonary disease .
[0049] Sample collection: 82 patients with active pulmonary tuberculosis, 108 healthy controls, 30 patients each with lung cancer, pneumonia and chronic obstructive pulmonary disease.
[0050] Collect the total RNA in the serum sample: add 700 μL Qiagen lysate to 200 μL serum sample and mix well, let stand for 5 minutes; add 140 μL chloroform, shake vigorously, let stand for 3 minutes; 12000 rpm, 4 ℃ for 15 minutes and take For the supernatant, add 1.5 times the volume of absolute ethanol and mix well; add the above mixture to the column, centrifuge at 8000 rpm for 18 seconds, discard the collected solution; add 700 μL RWT solution, centrifuge at 8000 rpm for 18 seconds, di...
Embodiment 3
[0066] Example 3 Establishment of specific serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 compositions for active pulmonary tuberculosis
[0067]Using MedCalc software to calculate the ROC curve of single serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 in the diagnosis of active pulmonary tuberculosis, including sensitivity, specificity and area under the curve (AUC) , the results showed that the AUCs of serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 were 0.723, 0.711, 0.702, 0.706, and the sensitivities were 51.2%, 67.5%, 94.9% respectively %, 90.1%, and the specificities were 87.4%, 70.5, 36.4%, and 44.2%, respectively. The results showed that the sensitivity and specificity of a single serum miRNA in the diagnosis of active pulmonary tuberculosis were not high.
[0068] Using the Logistic stepwise regression model to calculate the ROC curve of serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 composition in the diagnosis of a...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com